“Is anyone else mystified about CD16-17? Whe
Post# of 148151
Where's the protocol approval? What's the hold-up?”
Based on the PR from yesterday, it appears CYDY is taking their time with the trial protocol, to include IV infusion followed by multiple weeks of one sub-Q dose per week. This is what should’ve happened last year and I’m glad they are taking the time to develop a trail that will reach the primary endpoint. I’m willing to wait for that and expect an update on the protocol at the next CC.